| Mrs Carie Gertrude Bussey, CNM ARNP | |
|
615 Lilly Rd Ne Ste 200, Olympia, WA 98506-5137 | |
| (360) 413-8749 | |
| Not Available |
| Full Name | Mrs Carie Gertrude Bussey |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 615 Lilly Rd Ne Ste 200, Olympia, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952486318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | AP30007469 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Peter Hospital | Olympia, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 6709782600 | 393 |
News Archive
EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.
As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside -; and some may want to get a tan. But a new public service advertisement from the American Academy of Dermatology encourages those who are thinking of tanning to think again.
GOP presidential hopeful Newt Gingrich's health care consulting company filed for bankruptcy Thursday. The Center for Health Transformation charged up to $200,000 annually to drugmakers, insurers and hospitals for Gingrich's advice and may have suffered after he stepped down to seek the GOP nomination for president, reports say.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Therapeutic cancer vaccines, which stimulate the body's immune system to target and destroy cancer cells, are being used in combination with conventional chemotherapy with growing success, as described in several illuminating articles in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.
As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside -; and some may want to get a tan. But a new public service advertisement from the American Academy of Dermatology encourages those who are thinking of tanning to think again.
GOP presidential hopeful Newt Gingrich's health care consulting company filed for bankruptcy Thursday. The Center for Health Transformation charged up to $200,000 annually to drugmakers, insurers and hospitals for Gingrich's advice and may have suffered after he stepped down to seek the GOP nomination for president, reports say.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Therapeutic cancer vaccines, which stimulate the body's immune system to target and destroy cancer cells, are being used in combination with conventional chemotherapy with growing success, as described in several illuminating articles in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619176997 PECOS PAC ID: 7719873496 Enrollment ID: O20040227000744 |
News Archive
EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.
As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside -; and some may want to get a tan. But a new public service advertisement from the American Academy of Dermatology encourages those who are thinking of tanning to think again.
GOP presidential hopeful Newt Gingrich's health care consulting company filed for bankruptcy Thursday. The Center for Health Transformation charged up to $200,000 annually to drugmakers, insurers and hospitals for Gingrich's advice and may have suffered after he stepped down to seek the GOP nomination for president, reports say.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Therapeutic cancer vaccines, which stimulate the body's immune system to target and destroy cancer cells, are being used in combination with conventional chemotherapy with growing success, as described in several illuminating articles in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc.
› Verified 8 days ago
| Entity Name | Olympia Obstetrics & Gynecology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922045848 PECOS PAC ID: 8426086802 Enrollment ID: O20050727000693 |
News Archive
EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.
As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside -; and some may want to get a tan. But a new public service advertisement from the American Academy of Dermatology encourages those who are thinking of tanning to think again.
GOP presidential hopeful Newt Gingrich's health care consulting company filed for bankruptcy Thursday. The Center for Health Transformation charged up to $200,000 annually to drugmakers, insurers and hospitals for Gingrich's advice and may have suffered after he stepped down to seek the GOP nomination for president, reports say.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Therapeutic cancer vaccines, which stimulate the body's immune system to target and destroy cancer cells, are being used in combination with conventional chemotherapy with growing success, as described in several illuminating articles in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Carie Gertrude Bussey, CNM ARNP 2805 Orange St Se, Olympia, WA 98501 Ph: (360) 786-9456 | Mrs Carie Gertrude Bussey, CNM ARNP 615 Lilly Rd Ne Ste 200, Olympia, WA 98506-5137 Ph: (360) 413-8749 |
News Archive
EpiCept Corporation today announced that Ceplene (histamine dihydrochloride) has been highlighted in two separate reports issued recently reviewing 2008 drug approvals in the European Union.
As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside -; and some may want to get a tan. But a new public service advertisement from the American Academy of Dermatology encourages those who are thinking of tanning to think again.
GOP presidential hopeful Newt Gingrich's health care consulting company filed for bankruptcy Thursday. The Center for Health Transformation charged up to $200,000 annually to drugmakers, insurers and hospitals for Gingrich's advice and may have suffered after he stepped down to seek the GOP nomination for president, reports say.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Therapeutic cancer vaccines, which stimulate the body's immune system to target and destroy cancer cells, are being used in combination with conventional chemotherapy with growing success, as described in several illuminating articles in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc.
› Verified 8 days ago
Morgan Zentner, ARNP Advanced Practice Midwife Medicare: May Accept Medicare Assignments Practice Location: 205 Lilly Rd Ne, Bldg B Suite C, Olympia, WA 98506 Phone: 360-456-0555 Fax: 360-456-0721 | |
Amanda Nicole Clauson, CNM, ARNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 615 Lilly Rd Ne Ste 200, Olympia, WA 98506 Phone: 360-413-8413 | |
Katie Elizabeth Wodaege, CNM, ARNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 615 Lilly Rd Ne Ste 200, Olympia, WA 98506 Phone: 360-413-8413 Fax: 360-413-7143 | |
Mrs. Sharon A Hinz, CNM,ARNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 615 Lilly Rd Ne Ste 200, Olympia, WA 98506 Phone: 360-413-8413 Fax: 360-413-7143 | |
Shaneen S Fernandez, DNP, CNM, ARNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 Fax: 360-923-7089 | |
Doris A. Hahn, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 Fax: 360-923-7089 | |
Julianne Swift, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7500 |